cp wire

CP Wire Articles

LEO Pharma and PellePharm Announce Collaboration to Advance Rare Skin Disease Therapies Worth up to $760 Million
  • LEO Pharma is committed to$70 million comprised of equity financing and financial R&D support
  • PellePharm and its stockholders could receive up to an additional $690 million... read more
Tue, 11/20/18 - 09:56 am
PDUFA Date for Postpartum Depression Drug Delayed Three months
  • The new PDUFA date is March 19, 2019
  • The FDA has not requested any additional clinical data or any additional information from the Company as part of the extension


... read more

Tue, 11/20/18 - 09:23 am
Inflazome Completes $45 Million Series B Round

Inflazome, a pioneering inflammasome company developing small molecule drugs that block harmful inflammation, today announces the successful completion of a Series B financing round of €40 million... read more

Mon, 11/19/18 - 09:19 am
Rocket Pharmaceuticals' IND for Gene Therapy for Immune Disorder Cleared by FDA
  • Without a successful bone marrow transplant, mortality in patients with severe LAD-I is 60-75% prior to the age of 2
  • The disease occurs in approximately 1 in 1 million births... read more
Mon, 11/19/18 - 08:59 am
Immunicum Announces Collaboration with Merck KGaA and Pfizer to Evaluate Cell Therapy Treatment in Combination with Avelumab

Immunicum will initiate a study of ilixadencel in the fourth quarter of 2018. Following completion of the Ib portion of the study, a Phase II study will be conducted using the checkpoint inhibitor... read more

Fri, 11/16/18 - 08:28 am

Pages